Article -> Article Details
| Title | Oral Anticoagulants Market Share Strategy, Regional Analysis and Growth Forecast to 2030 |
|---|---|
| Category | Fitness Health --> Health Articles |
| Meta Keywords | Oral Anticoagulants Market Share |
| Owner | Vaibhav |
| Description | |
|
Anticoagulant is
a drug, when added to blood, prevents it from clotting. Anticoagulants achieve
their effect by suppressing the synthesis or function of various clotting
factors that are normally present in the blood. Such drugs are often used to
prevent the formation of blood clots (thrombi) in the veins or arteries or the
enlargement of a clot that is circulating in the bloodstream. The Oral Anticoagulants Market Share is expected to reach USD
37,617.33 Million by 2030 at 8.90% CAGR during the forecast period 2022-2030. Increasing
cardiovascular disorders, rising geriatric population, and increasing surgical
procedures support the growth of the global Oral Anticoagulants Market in
recent years. However, the high cost is likely to restrain market
growth over the forecast period. Major Key
Players: Market Research Future (MRFR) recognizes the following
companies as the key players in the global Oral Anticoagulants Market
Share that includes AstraZeneca, Plc (UK), Pfizer (US), Boehringer
Ingelheim GmbH (Germany), Daiichi Sankyo Company Ltd (Japan), Abbott
Laboratories (US), Eli Lilly and Company (US), GlaxoSmithKline plc (UK) Portola
Pharmaceuticals Inc. (US), Medicure (Canada), Johnson & Johnson Services
Inc. (US), and others. Segment Analysis The global oral anticoagulants market has been segmented into
product, disease indication, distribution channel, and region. Based on
product, the injectable
anticoagulants and oral anticoagulants market has been segmented
into novel oral anticoagulant and warfarin. On the basis of disease indication,
the global oral anticoagulants market has been segmented into atrial
fibrillation (AF)/ stroke prevention and deep vein thrombosis/ pulmonary embolism,
and others. On the basis of distribution channel, the global oral
anticoagulants market has been segmented into hospital pharmacies, retail
pharmacies, and E-commerce. Regional
Analysis Geographically, the Americas is
expected to dominate the global Oral Anticoagulants Market Share. This is
owing to increasing cardiovascular disorders and increasing surgical
procedures. Europe showed a considerable amount of growth in the market due to
the rising geriatric population. Asia-Pacific is estimated to be the fastest
growing region in the market. This is owing to increasing cardiovascular
disorders and rising geriatric population. On the other hand, the Middle East
& Africa has the least share of the market. About Market Research
Future At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services. MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions. In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members. Contact us: Market Research Future
(part of Wantstats Research and Media Private Limited), 99 Hudson Street, 5Th Floor, New York, New York 10013 United States of America +1 646 845 9312 | |